- ICH GCP
- EU: n kliinisten tutkimusten rekisteri
Kliiniset tutkimukset Nct sivu
Clinical Trial Results:
A 24-week Randomized, Double-Blind, Parallel-Group, Multi-Centre, Active-Controlled (Metformin or Metformin Combined with Fenofibrate) Study to Evaluate the Lipid Metabolic Effects, Glycaemic Effects, Safety and Tolerability of Tesaglitazar Therapy in Patients with Type 2 Diabetes and Low HDL-Cholesterol on a Fixed Background Therapy with a Statin.
Summary | |
EudraCT number | 2004-002550-56 |
Trial protocol | HU FI DE CZ |
Global completion date | 16 Dec 2007 |
Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
Results information | |
Results version number | v1(current) |
This version publication date | 22 Sep 2016 |
First version publication date | 22 Sep 2016 |
Other versions | |
Summary report(s) | D6160C0003-CSR |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.